Advertisement
Opinion

Opinion Opinion articles provide a forum for expression of views, and responses to previous statements, on a range of topical, emerging and controversial issues.

See all article types »

Dendritic Cell Status Modulates the Outcome of HIV-Related B Cell Disease Progression

  • Published: August 25, 2011
  • DOI: 10.1371/journal.ppat.1002154

Reader Comments (2)

Post a new comment on this article

Typesetting Error: Duplicated Paragraph

Posted by PLoS_Pathogens on 13 Sep 2011 at 18:36 GMT

The overall outcome of HIV disease may depend on the host's capacity to maintain dendritic cell (DC) homeostasis at mucosalsites, where DC populations, one of the earliest cell types to be exposed to the virus, present an inherent capacity to modulate the balance between tolerance and protection. DCs may influence mucosal B cell responses against HIV through contact and/or production of B cell growth factors such as B lymphocyte stimulator (BLyS/BAFF), which in turn modulate the outcome of CD4+ T cell HIV effectors/targets. Recent observations of HIV/SIV infections in non-pathogenic animal models and from mucosal vaccination of nonhuman primates suggest that maintenance of systemic integrity may be achieved through constraining highly efficient immune responses to mucosal sites.
http://plospathogens.org/article/info:doi/10.1371/journal.ppat.1002154#article1.body1.sec4.p3

An error was introduced in the preparation of this article for publication. Please note that this paragraph is a duplicate of the first paragraph in the article and as such, is not intended to be here.

No competing interests declared.